Stable enhanced green fluorescent protein expression after differentiation and transplantation of reporter human induced pluripotent stem cells generated by AAVS1 transcription activator-like effector nucleases

Stem Cells Translational Medicine

Volumn 3, Issue 7, 2014, Pages 821-835

  Luo, Yongquan ^a   Liu, Chengyu ^b   Cerbini, Trevor ^a   San, Hong ^b   Lin, Yongshun ^b   Chen, Guokai ^b   Rao, Mahendra S ^a   Zou, Jizhong ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

AAVS1; Differentiation; Genome editing; Human induced pluripotent stem cells; Transcription activator like effector nuclease (TALEN); Transplantation

Indexed keywords

CD34 ANTIGEN; ELONGATION FACTOR 1ALPHA; GELATINASE A; GREEN FLUORESCENT PROTEIN; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; NUCLEASE; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LIN28; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA END JOINING REPAIR; EGFP GENE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE; GENE EXPRESSION; GENE LOCUS; GENE TARGETING; HEART INFARCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MOUSE; MUTAGENESIS; NONHUMAN; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; SOUTHERN BLOTTING;

AAVS1; DIFFERENTIATION; GENOME EDITING; HUMAN INDUCED PLURIPOTENT STEM CELLS; TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASE (TALEN); TRANSPLANTATION;

ACTINS; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRACKING; CELLS, CULTURED; CYTOMEGALOVIRUS; DEOXYRIBONUCLEASES; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENE SILENCING; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; NADH DEHYDROGENASE; PEPTIDE ELONGATION FACTOR 1; PROMOTER REGIONS, GENETIC; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 84903539809     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0212     Document Type: Article

References (29)

1. RaoMS, Malik N. Assessing iPSC reprogramming methods for their suitability in translational medicine. J Cell Biochem 2012; 113: 3061-3068.
2. Walia B, Satija N, Tripathi RP et al. Induced pluripotent stem cells: Fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine. Stem Cell Rev 2012; 8: 100-115.
3. Deacon T, Dinsmore J, Costantini LC et al. Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation. Exp Neurol 1998; 149: 28-41.
4. Hentze H, GraichenR, ColmanA. Cell therapy and the safety of embryonic stem cell-derived grafts. Trends Biotechnol 2007; 25: 24-32.
5. Zou J, Maeder ML, Mali P et al. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 2009; 5: 97-110.
6. Boch J, Bonas U. Xanthomonas AvrBs3 family-type III effectors: Discovery and function. Annu Rev Phytopathol 2010; 48: 419-436.
7. Hockemeyer D, WangH, Kiani S et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 2011; 29: 731-734.
8. Ogata T, Kozuka T, Kanda T. Identification of an insulator in AAVS1, a preferred region for integration of adeno-associated virus DNA. J Virol 2003; 77: 9000-9007.
9. Smith JR, Maguire S, Davis LA et al. Robust, persistent transgene expression inhuman embryonic stem cells is achieved with AAVS1-targeted integration. STEM CELLS 2008; 26: 496-504.
10. Zou J, Sweeney CL, Chou BK et al. Oxidasedeficient neutrophils from X-linked chronic granulomatous disease iPS cells: Functional correction by zinc finger nuclease-mediated safe harbor targeting. Blood 2011; 117: 5561-5572.
11. Lamartina S, Sporeno E, Fattori E et al. Characteristics of the adeno-associated virus preintegration site in human chromosome 19: Open chromatin conformation and transcription-competent environment. J Virol 2000; 74: 7671-7677.
12. Cermak T, Doyle EL, Christian M et al. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 2011; 39: e82.
13. Miller JC, Tan S, Qiao G et al. A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 2011; 29: 143-148.
14. Chou BK, Mali P, Huang X et al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 2011; 21: 518-529.
15. Chen G, Gulbranson DR, Hou Z et al. Chemically defined conditions for human iPSC derivation and culture. Nat Methods 2011; 8: 424-429.
16. Lian X, Hsiao C, WilsonGet al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci USA 2012; 109: E1848-E1857.
17. Mayer-Proschel M, Kalyani AJ, Mujtaba T et al. Isolation of lineage-restricted neuronal precursors from multipotent neuroepithelial stem cells. Neuron 1997; 19: 773-785.
18. Tarnavski O, McMullen JR, Schinke M et al. Mouse cardiac surgery: Comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol Genomics 2004; 16: 349-360.
19. DeKelver RC, Choi VM, Moehle EA et al. Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome. Genome Res 2010; 20: 1133-1142.
20. Hockemeyer D, Soldner F, Beard C et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol 2009; 27: 851-857.
21. Olive DM, Al-Mulla W, Simsek M et al. The human cytomegalovirus immediate early enhancer-promoter is responsive to activation by the adenovirus-5 13S E1A gene. Arch Virol 1990; 112: 67-80.
22. Chen CM, Krohn J, Bhattacharya S et al. A comparison of exogenous promoter activity at the ROSA26 locus using a FiC31 integrase mediated cassette exchange approach in mouse ES cells. PLoS One 2011; 6: e23376.
23. Xia X, Zhang Y, Zieth CR et al. Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoterdependent manner. Stem Cells Dev 2007; 16: 167-176.
24. SanjanaNE, CongL, ZhouYetal. Atranscription activator-like effector toolbox for genome engineering. Nat Protoc 2012; 7: 171-192.
25. Irion S, Luche H, Gadue P et al. Identification and targeting of the ROSA26 locus in human embryonic stem cells. Nat Biotechnol 2007; 25: 1477-1482.
26. Bronson SK, Plaehn EG, Kluckman KD et al. Single-copy transgenic mice with chosen-site integration. Proc Natl Acad Sci USA 1996; 93: 9067-9072.
27. Macarthur CC, Xue H, Van Hoof D et al. Chromatin insulator elements block transgene silencing in engineered human embryonic stem cell lines at a defined chromosome 13 locus. Stem Cells Dev 2012; 21: 191-205.
28. van Laake LW, Passier R, Monshouwer-Kloots J et al. Human embryonic stem cellderived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res 2007; 1: 9-24.
29. Ng SY, Wong CK, Tsang SY. Differential gene expressions in atrial and ventricular myocytes: Insights into the road of applying embryonic stem cell-derived cardiomyocytes for future therapies. Am J Physiol Cell Physiol 2010; 299: C1234-C1249.